University of Helsinki
The Good Side of a Virus
Our research group develops vaccines against cancer. How do we do that? We modify viruses to seek and specifically destroy cancer cells whilst leaving live, healthy cells undamaged. During this process, we reprogram the immune system to store important information about the cancer to prevent it from emerging in the future. These special viruses are called oncolytic viruses and once combined with special features present in the tumour, they present a lethal strategy to destroy cancer. They work like a vaccine, teaching our bodies how to recognise emerging tumours as external intruders in advance of them becoming established, life-threatening cancers.
Learn more about Manlio Fusciello from Professor Vincenzo Cerullo ImmunoViroTherapy lab.
